Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Sluggish enrollment leads Boundless Bio to make 'modest' layoffs 5 months after $100M IPO
Fierce Biotech
Tuesday, August 13, 2024 - 11:32am
tags:
Boundless Bio, layoffs, clinical trials, IPOs, BBI-355
Carlyle to buy Baxter's kidney-care spinoff Vantive for $3.8 billion
Reuters
Tuesday, August 13, 2024 - 11:29am
tags:
Carlyle Group, Baxter, M&A, Vantive, Medtech
A potential MS ‘game changer’ could bring more safety to the table — even against viruses
Pharma Voice
Tuesday, August 13, 2024 - 11:28am
tags:
Immunic, vidofludimus calcium, MS, multiple sclerosis
Galderma gets FDA nod for prurigo nodularis therapy
Pharmaphorum
Tuesday, August 13, 2024 - 11:26am
tags:
Galderma, FDA, Nemluvio, prurigo nodularis
Skyrizi soars to top of Rx, OTC pharma brand rankings in July
Medical Marketing and Media
Tuesday, August 13, 2024 - 11:25am
tags:
Skyrizi, AbbVie, television ads
Novo Nordisk plots 2024 FDA filing for once-weekly insulin and semaglutide combo
Fierce Pharma
Monday, August 12, 2024 - 6:01pm
tags:
Novo Nordisk, FDA, insulin, semaglutide, Icosema
Novartis loses initial bid to block generic of best-selling heart drug
Reuters
Monday, August 12, 2024 - 5:57pm
tags:
Novartis, legal, MSN Pharmaceuticals, Entresto, heart failure, generics
UCB leads pharma in CX, according to DT Consulting survey
Medical Marketing and Media
Monday, August 12, 2024 - 5:56pm
tags:
UCB Pharma, Customer Experience, physicians, HCPs
Senseonics Looks to Stand Apart from the Big 3 in Diabetes Tech
Medical Devices and Diagnostics Industry
Monday, August 12, 2024 - 5:54pm
tags:
Medtech, Senseonics, continuous glucose monitoring, Eversense, diabetes, CGMs
5 things to know ahead of the Medicare drug price announcement
Beckers Hospital Review
Monday, August 12, 2024 - 5:53pm
tags:
Medicare, Inflation Reduction Act, drug pricing, CMS
Novartis' Complement Inhibitor Fabhalta Approved for IgAN
Contract Pharma
Monday, August 12, 2024 - 5:52pm
tags:
FDA, Novartis, Fabhalta, primary IgA nephropathy
Pfizer, looking to expand RSV vaccine's reach, touts its benefits in immunocompromised adults
Fierce Pharma
Monday, August 12, 2024 - 11:42am
tags:
Pfizer, RSV, vaccines, Abrysvo, immunocompromised patients
Revance Therapeutics shares soar on takeover by Crown Labs
Markewatch
Monday, August 12, 2024 - 11:41am
tags:
Revance Therapeutics, Crown Laboratories, M&A
Is COVID endemic yet? Yep, says the CDC. Here's what that means
NPR
Monday, August 12, 2024 - 11:39am
tags:
COVID-19, CDC, endemic, pandemic
Ascendis scores hard-fought FDA nod for hormone replacement therapy Yorvipath
Fierce Pharma
Monday, August 12, 2024 - 11:35am
tags:
Ascendis Pharma, hypoparathyroidism, FDA, Yorvipath
Stryker to acquire AI-assisted virtual care company Care.ai
Mass Device
Monday, August 12, 2024 - 11:33am
tags:
Medtech, M&A, Stryker, Care.ai, artificial intelligence
Australian biotech's cortisol blocker fails to improve attention in phase 2 depression study
Fierce Biotech
Monday, August 12, 2024 - 11:31am
tags:
Actinogen, cortisol blockers, depression, Alzheimer's disease, clinical trials
Halda raises $126M to advance 'hold and kill' solid tumor drugs into the clinic
Fierce Biotech
Monday, August 12, 2024 - 11:30am
tags:
Halda, R&D, solid tumors, funding
Weight-loss drugs like Wegovy may help stave off some cancers
NPR
Monday, August 12, 2024 - 11:28am
tags:
cancer, GLP-1 agonist, Wegovy, Zepbound, Novo Nordisk, Eli Lilly
FDA grants IND clearance for TG Therapeutics’ trial of multiple sclerosis treatment
Clinical Trials Arena
Monday, August 12, 2024 - 11:25am
tags:
Precision Biosciences, TG Therapeutics, FDA, azer-cel, progressive MS, MS, clinical trials

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.